-

Verasonics Appoints New Senior Vice President, Research & Development

KIRKLAND, Wash.--(BUSINESS WIRE)--Verasonics, Inc. announced today the appointment of Richard Van Bibber, Ph.D., as senior vice president of research & development. In this role, Van Bibber will lead the company’s R&D organization and advance its innovation strategy for ultrasound research and product development.

Van Bibber's extensive experience in medical technology innovation, combined with his expertise in diagnostic ultrasound, makes him a valuable addition to our leadership team.

Share

“I am pleased to welcome Rich to Verasonics,” said Jon K. Daigle, CEO of Verasonics. “His extensive experience in medical technology innovation, combined with his expertise in diagnostic ultrasound, makes him a valuable addition to our leadership team. Rich’s proven ability to lead the development of breakthrough technologies will help advance our mission of empowering ultrasound innovation worldwide.”

Van Bibber brings nearly 30 years of experience leading the development of innovative medical technologies, with a proven track record of bringing medical device products from concept through commercialization. Throughout his career, he has built and led high-performing engineering teams and driven the development of complex hardware and software solutions.

Most recently, Van Bibber served as Chief Technology Officer at Caeli Vascular and GenPrime, Inc., where he led product design, development, verification, and validation activities. He also brings experience with diagnostic ultrasound technologies, including TTE, TEE, ICE, and 3D echocardiography, with expertise spanning quantitative imaging, image-guided procedures, and advanced medical device development.

Van Bibber holds a Ph.D. in Physiology and Biophysics from the University of Washington and a Bachelor of Science in Physiological Science from UCLA.

About Verasonics, Inc.

Headquartered in Kirkland, Washington, USA, Verasonics is a privately held company founded in 2001. Verasonics, the leader in research ultrasound, empowers ultrasound innovation worldwide by providing flexible ultrasound platforms for research, development, and commercialization. Verasonics solutions are used across biomedical ultrasound, materials science, earth sciences, and acoustics to help accelerate innovation from concept to market. Verasonics also licenses its technology to companies for use in their commercial products.

Learn more by visiting the Verasonics website or following us on LinkedIn and X.

Contacts

Media Contact:
Verasonics, Inc.
James Schada
T: 425-439-7235
E: jamesschada@verasonics.com

Verasonics, Inc.


Release Summary
Verasonics names Richard Van Bibber, Ph.D. as SVP of R&D. He will lead ultrasound research innovation and advance product development strategy.
Release Versions

Contacts

Media Contact:
Verasonics, Inc.
James Schada
T: 425-439-7235
E: jamesschada@verasonics.com

Social Media Profiles
More News From Verasonics, Inc.

Verasonics Celebrates 25 Years of Empowering Ultrasound Innovation

KIRKLAND, Wash.--(BUSINESS WIRE)--Verasonics celebrates 25 years of empowering ultrasound innovation and advancing research, development, and commercialization worldwide....

Verasonics Announces Vantage® NXT Platform Update Featuring Encoder Integration, Focused Ultrasound 2D/3D Software, New 8 MHz Matrix Array Transducer

KIRKLAND, Wash.--(BUSINESS WIRE)--Verasonics, Inc., the leader in research ultrasound, today announced the release of a significant update for its Vantage NXT Research Ultrasound platform. The release introduces advanced hardware integration capabilities, expanded support for focused ultrasound (FUS) applications, enhanced real-time data synchronization tools, and compatibility with the new M8dV Matrix Array Transducer. The update is available immediately to all Vantage NXT customers. Key Featu...

Verasonics Announces Strategic Collaboration with ImFusion to Advance Ultrasound Innovations to the Clinic

KIRKLAND, Wash.--(BUSINESS WIRE)--Verasonics, the leader in advanced ultrasound research and development, is pleased to announce a new collaboration with ImFusion GmbH, a globally recognized provider of advanced medical image computing software. This collaboration brings together Verasonics’ industry-leading programmable Vantage® NXT Research Ultrasound Systems with ImFusion’s powerful software platform for real-time image reconstruction, 2D/3D visualization, and AI-powered workflows. Through t...
Back to Newsroom